2-23757462-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_017552.4(ATAD2B):c.4034C>T(p.Pro1345Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00004 in 1,523,448 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017552.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATAD2B | NM_017552.4 | c.4034C>T | p.Pro1345Leu | missense_variant | 25/28 | ENST00000238789.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATAD2B | ENST00000238789.10 | c.4034C>T | p.Pro1345Leu | missense_variant | 25/28 | 5 | NM_017552.4 | P1 | |
ATAD2B | ENST00000381024.4 | c.1862C>T | p.Pro621Leu | missense_variant | 9/12 | 1 | |||
ATAD2B | ENST00000474583.5 | n.3179C>T | non_coding_transcript_exon_variant | 16/19 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000288 AC: 5AN: 173412Hom.: 0 AF XY: 0.0000436 AC XY: 4AN XY: 91848
GnomAD4 exome AF: 0.0000430 AC: 59AN: 1371332Hom.: 0 Cov.: 31 AF XY: 0.0000489 AC XY: 33AN XY: 674346
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2023 | The c.4034C>T (p.P1345L) alteration is located in exon 25 (coding exon 25) of the ATAD2B gene. This alteration results from a C to T substitution at nucleotide position 4034, causing the proline (P) at amino acid position 1345 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at